Clinical Trials Directory

Trials / Completed

CompletedNCT04348760

Study of Inflammatory Markers and Symptom Severity in Personalized Nutritional Intervention in IBS

Study of Two Inflammatory Cytokines, BAFF and PAF, and Their Clinical Relevance Before and After a Personalized Nutritional Intervention in IBS Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
GEK Srl · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Irritable Bowel Syndrome (IBS) is a widespread disease with variable symptoms that have an important impact on the quality of life. Despite the prevalence of IBS, its etiology and pathophysiology are still to be fully understood, but immune response is known to be involved. In this study, the investigators researched the variation of two specific cytokines, B-cell activating factor (BAFF) and platelet-activating factor (PAF), the levels of food-specific IgG and the symptom severity, using Irritable Bowel Syndrome - Symptom Severity Score (IBS-SSS), following a personalized an unrestricted-calorie diet.

Detailed description

The investigators enrolled 30 subjects with diagnosis of IBS, according to Rome-IV criteria, whose inflammatory markers were measured at baseline and after 6 weeks of dietary intervention. The subjects were monitored in a general practice outpatient setting (GP) and nutritional advice was offered remotely via two telephone sessions with a nutritionist. The researchers investigated the variation of two specific cytokines, B-cell activating factor (BAFF) and platelet-activating factor (PAF), the levels of food-specific IgG and the symptom severity, using Irritable Bowel Syndrome - Symptom Severity Score (IBS-SSS). Data monitoring was ensured by an external monitor (Hippocrates Research, Genova, Italy). All data entry was in accordance with GCP protocol, and AE were classified using CTCAE 4.0

Conditions

Interventions

TypeNameDescription
BEHAVIORALRotation DietBased on the food-specific IgG measurement and relative distribution, a personalized food profile was created for each subject identifying 1 to 3 relevant food groups/nutritional clusters. Subjects were then instructed to avoid the foods highlighted in their personal food profile in certain days of the week, and to assume them in 7 of the 21 meals of the week. No calorie restriction was imposed in the diet.

Timeline

Start date
2019-05-01
Primary completion
2019-07-30
Completion
2019-07-30
First posted
2020-04-16
Last updated
2020-04-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04348760. Inclusion in this directory is not an endorsement.